Detalhe da pesquisa
1.
Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and Denmark.
Scand Cardiovasc J
; 48(3): 138-47, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24650118
2.
Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway.
Appl Health Econ Health Policy
; 16(4): 569-577, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-29923173